Home > Mark L Metersky, CHEST 2018 – Empiric antibiotic therapy: challenges and recommendations
Airway and Lung Infection, Respiratory Intensive Care, Ventilation

Mark L Metersky, CHEST 2018 – Empiric antibiotic therapy: challenges and recommendations

Published Online: October 12th 2018

Mark L Metersky (University of Connecticut School of Medicine, Farmington, CT, US) discusses current recommendations and guidelines with respect to the use of empiric antibiotic therapy in patients with ventilator-associated pneumonia.

Questions

1. What are the major challenges of empiric antibiotic therapy in patients with ventilator-associated pneumonia? (0:10)
2. How are patients defined in terms of risk when selecting antibiotic treatment? (1:49)
3. What are the recommendations of the latest guidelines in the treatment of patients with risk factors for multidrug resistance and high mortality risk? (2:59)
4. What is the current recommended antibiotic treatment duration for high- and low-risk patients? (3:25)
5. What are the limitations of the current guidelines? (6:03)

Speaker disclosure: Mark L Metersky has nothing to disclose in relation to this video interview.

Filmed at the CHEST Annual Meeting, San Antonio, TX, US, October 2018.

Related Videos In Ventilation
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar